References
Peck GL, Gross EG, Butkus D, DiGiovanna JJ (1982) Chemoprevention of basal cell carcinomas with isotretinoin. J Am Acad Dermatol 6:815–823
Van Voorst Vader PC, Driessen LHHM, Kallenberg CGM (1983) Basal cell nevus syndrome: immune status, etretinate therapy and etretinate hepatitis. Br J Dermatol 108:109 (abstract)
Moriarty M, Dunn J, Darragh A, Lambe R, Brick I (1982) Etretinate in treatment of actinic keratosis. Lancet 1:364–365
Schnitzler L, Schubert B, Verret JL (1980) Essai de prévention des épithéliomas cutanés par le rétinoïde aromatique. Ann Dermatol Venereol 107:657–663
Claudy AL, Soulas G, Lauras B, FreyconMT, Le Petit JC, Fraisse J (1982) Xeroderma Pigmentosum et traitement au long cours par le rétinoide aromatique. Ann Dermatol Venereol 109: 271–274
Braun-Falco O, Galosi A, Dorn M, Plewig G (1982) Tumorprophylaxe bei Xeroderma pigmentosum mit aromatischem Retinoid (Ro 10-9359). Hautarzt 33:445–448
Bollag W (1983) Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology. Lancet 1:860–863
Bootsma D, Mulder MP, Pot F, Cohen JA (1970) Different inherited levels of DNA repair replication in xeroderma pigmentosum cell strains after exposure to ultraviolet irradiation. Mutat Res 9:507–516
Friedberg EC, Ehmann UK, Williams JI (1979) Human diseases associated with defective DNA repair. Adv Radiat Biol 8:85–174
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Voorst Vader, P.C., Jaspers, N.G.J. & van der Kamp, A.W.M. Retinoic acid and defective UV light induced DNA excision repair in xeroderma pigmentosum: Absence of ameliorating effect. Arch Dermatol Res 276, 201–202 (1984). https://doi.org/10.1007/BF00414021
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00414021